Literature DB >> 29382566

Overexpression of the 14-3-3γ protein in uterine leiomyoma cells results in growth retardation and increased apoptosis.

Qi Shen1, Xiaoli Hu1, Lulu Zhou1, Shuangwei Zou1, Lu-Zhe Sun2, Xueqiong Zhu3.   

Abstract

Protein 14-3-3γ was significantly reduced in human uterine leiomyoma compared to the adjacent normal myometrium tissue. To investigate the possible link between the reduced 14-3-3γ expression and uterine leiomyoma growth, we have overexpressed 14-3-3γ protein in uterine leiomyomal cells and its effects on cell proliferation and apoptosis were analyzed. Over-expression of 14-3-3γ was achieved by transducing into two types of uterine leiomyoma cells (primary culture cells and immortal stem cells) with a 14-3-3γ expressing adenovirus vector. Differentially expressed proteins were screened by the proteomics tool (TMT-LCTMS), followed by PANTHER database analysis to single out specifically modified signaling pathway proteins, which were confirmed by Phospho-MAPK Antibody Array and Western blots analysis. The results showed that increase in 14-3-3γ expression in both two types of human uterine leiomyoma cells inhibited cell proliferation and induced apoptosis. Proteomic screening has found 42 proteins, among 5846, that were significantly affected. PANTHER database and GeneMANIA analysis of the differentially expressed proteins have found that proteins involved in apoptosis signaling and cytoskeletal/adhesion were among the ones affected the most. Further analysis of the key signaling pathways have found that over-expression of 14-3-3γ resulted in reductions in the phosphorylations of multiple signaling molecules, including AKT, pan, ERK1/2, GSK-3 α/β, MEK1/2, Foxo1 and Vimentin. In conclusion, the loss of 14-3-3γ may have causal effects on the growth of uterine leiomyoma, which may function through modifying multiple signaling pathways, including AKT-Foxo and/or MEK1/2-ERK1/2. Published by Elsevier Inc.

Entities:  

Keywords:  14-3-3γ; Apoptosis; Bioinformatics; Proliferation; Signaling pathway; Uterine leiomyoma

Mesh:

Substances:

Year:  2018        PMID: 29382566     DOI: 10.1016/j.cellsig.2018.01.025

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  4 in total

1.  Comparative proteomics study of proteins involved in induction of higher rates of cell death in mitoxantrone-resistant breast cancer cells MCF-7/MX exposed to TNF-α.

Authors:  Saeed Norouzi; Rezvan Yazdian Robati; Morteza Ghandadi; Khalil Abnous; Javad Behravan; Fatemeh Mosaffa
Journal:  Iran J Basic Med Sci       Date:  2020-05       Impact factor: 2.699

2.  Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis.

Authors:  C S Gallagher; N Mäkinen; H R Harris; N Rahmioglu; D I Chasman; S A Missmer; K T Zondervan; C C Morton; O Uimari; J P Cook; N Shigesi; T Ferreira; D R Velez-Edwards; T L Edwards; S Mortlock; Z Ruhioglu; F Day; C M Becker; V Karhunen; H Martikainen; M-R Järvelin; R M Cantor; P M Ridker; K L Terry; J E Buring; S D Gordon; S E Medland; G W Montgomery; D R Nyholt; D A Hinds; J Y Tung; J R B Perry; P A Lind; J N Painter; N G Martin; A P Morris
Journal:  Nat Commun       Date:  2019-10-24       Impact factor: 17.694

3.  YWHAG inhibits influenza a virus replication by suppressing the release of viral M2 protein.

Authors:  Haiying Mao; Lei Cao; Ting Xu; Xiaohan Xia; Peilei Ren; Pengfei Han; Chengfei Li; Xianfeng Hui; Xian Lin; Kun Huang; Meilin Jin
Journal:  Front Microbiol       Date:  2022-07-19       Impact factor: 6.064

4.  Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas.

Authors:  Qi Shen; Shuangwei Zou; Bo Sheng; Menghuang Zhao; Lu-Zhe Sun; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2019-09-03       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.